Paul Cross Consulting can assist in the design, set-up and management of clinical research studies involving genetically modified organisms (GMOs) or advanced therapy medicinal products (ATMPs), more commonly known as gene or cell therapy.

As an accredited Biosafety Officer (BSO), Dr Paul Cross has substantial experience of completing biosafety risk assessments, developing study procedures for ATMP studies, undertaking biological safety audits, and setting up and managing clinical trials of GMO vaccines.

*Please note, all work is completed virtually at the current time, due to the Covid-19 pandemic.

 Contact PCC for further information: